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In 2018, the UK Government’s Secretary of State for Health and Social Care articulated an 
ambition to increase healthy life expectancy by five years by 2035 for England, while also reducing 
the gap in this between the rich and the poor1. While we doubt that England – or indeed any high-
income country – could achieve this ambition, we describe a set of policies with the potential to 
make a significant contribution.  
 
Focus and approach  
 
The leading causes of years of life lost in England are tobacco use, unhealthy diet, alcohol 
consumption and physical inactivity2 and all of these behaviours are socio-economically patterned. 
Thus, changing them has the potential both to increase healthy life expectancy and to reduce the gap 
between rich and poor. Upward trends in life expectancy and healthy life expectancy in England 
have slowed since 20103,4. One plausible explanation for this is the impact of policies intended to 
reduce the national budget deficit5. While the focus of this paper is on tackling health behaviours, 
we recognise the need for co-ordinated action across multiple policy areas including targeting 
underlying, structural causes of health inequalities6. 
 
Two complementary approaches to prevention involve targeting individuals at high risk, and 
targeting whole populations 7. Here we emphasise the latter, using structural or policy interventions 
that create healthier environments – including physical, economic, digital, social and commercial 
environments. Healthier environments not only enable healthier behaviours in the wider population, 
but also provide contexts in which behaviour change resulting from targeting individuals at high 
risk is more likely to be sustained8-10. Both approaches are needed: targeting individuals through, 
for example, weight loss programmes without changing the environments that promote excess 
energy consumption is akin to treating people for cholera then sending them back to communities 
with contaminated water supplies. 
 
Some interventions targeting individuals engender inappropriately high expectations of 
effectiveness, particularly those arising from technological innovations that aim to motivate people 
to change their behaviour by informing them of their potentially reducible risks of disease. The 
evidence, however, does not support these expectations: such information has little or no impact on 
actual behaviour, which is driven much more powerfully by the physical, economic, social and 
commercial environments in which people live11,12. Changing these environments is where attention 
needs to focus if large gains in healthy life expectancy are to be achieved.  
 
Even small effect sizes matter: population-level interventions may have small impacts at the 
individual level but very wide reach, resulting in substantial overall population impact. For 
example, a sustained 13kcal/day reduction in energy intake in those aged 16-29 is estimated to 
reduce obesity by 7%13. Moreover, population-level interventions also have greater potential to 
achieve change equitably given their low demands upon the cognitive, social and material resources 
of individuals9,10. 
 
Interventions with potentially largest and most equitable effects 
 
Guided by these principles, informed both by evidence reviews and a meeting of UK population 
health experts, we generated a list of interventions with potentially the largest and most equity-
enhancing effects on healthy life expectancy (Panel). These comprise three broad categories: first, 
fiscal and economic interventions targeting the affordability of products and activities that harm 
health; second, interventions to restrict product marketing or to market healthier alternatives; and 
third, interventions to reduce the availability – in space, time or by age – of products or activities 
that harm health, or to increase the availability of products or activities that benefit health. 
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There is good evidence for effective interventions across all four sets of behaviours. The evidence is 
strongest – in terms of effect sizes to improve population health, reduce inequalities and certainty of 
effect – for fiscal and economic interventions that reduce the affordability of tobacco and alcohol, 
with growing evidence for sugar-sweetened drinks 14. These aim to correct market failures by 
internalising the external costs – including damage to population health – of harmful commodities. 
Fiscal and economic interventions showing most promise to increase physical activity are those that 
increase the affordability of walking, cycling and public transport and disincentivise driving15. 
 
Effective marketing interventions include banning or restricting advertising and marketing designed 
to persuade people to consume health-damaging products. They also include mass media campaigns 
that encourage people not to consume such products. Reducing exposure of children and adults to 
alcohol and unhealthy food marketing reduces their consumption16,17, and anti-tobacco campaigns 
reduce smoking prevalence and increase quitting rates18,19.  
 
Reducing the availability of products harmful to health – i.e. the ease with which they can be 
obtained – can be achieved by limiting where and when they are sold and to whom, as well as 
reformulating and re-sizing products to reduce their harmfulness20. Systemic approaches to increase 
physical activity include increasing public transport and the availability of places that are walkable, 
and reducing the convenience of car driving.  
 
Such interventions should not be considered in isolation. The application of a systemic approach 
predicts synergies between interventions, both within and across behavioural domains8. Responses 
by threatened industries – such as the tobacco industry reducing prices in advance of a tax increase 
to absorb the price rise21 – need to be anticipated to protect the health-enhancing impact of any set 
of policies.  
 
Overcoming barriers to implementation of population-level interventions 
 
Even the most efficacious interventions require supportive political and social environments for 
effective implementation. Industry opposition to policies that threaten their markets manifests in 
their lobbying both policy-makers and the public22. Public support for interventions is often critical 
for policy-makers23,24 and can be increased by communicating evidence of policy effectiveness25. 
The UK Soft Drinks Industry Levy attracted high levels of public support, showing that a public 
and political case for fiscal interventions can be made26. Framing the case for intervention in terms 
of human rights – such as the Right to Health or The Rights of the Child – also holds promise27,28.  
 
The effective implementation of the population interventions described here will be hard to achieve 
– requiring strong leadership to overcome potentially high political costs – but will be essential if 
we are to increase healthy life expectancy for the poorest as well as the rich by any amount, let 
alone by 5 years by 2035.  
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Panel: Population-level interventions with likely largest effects on healthy life expectancy and 
inequalities 
 
Tobacco Control 
Fiscal and economic 
Tax to ensure annual real price increases in tobacco 
Reform current tobacco taxes to ensure consistent 
unit prices: e.g. close price gap between 
manufactured and hand-rolled tobacco 
Marketing 
Well-designed mass media campaigns 
Pack inserts on benefits of quitting and sign-posting 
to smoking cessation services 
Availability 
Raise legal age to buy tobacco from 18 to 21 years 
 
Alcohol Control  
Fiscal and economic 
Legislate for Minimum Unit Price 
Tax to ensure annual real price increases in alcohol 
Reform current taxes on alcohol to ensure 
consistent unit prices: i.e. tax should be 
proportional to percentage alcohol by volume 
Marketing 
Restrict advertising and sponsorship to reduce 
exposure to children 
Availability 
Reduce availability - spatial, temporal and age 
based: e.g. cap number and density of outlets; Early 
Morning Restriction Orders; enforce existing 
minimum age purchase laws 
 
 
 
 
 
 
 
 
 
Food-Related 
Fiscal and economic 
Tax to incentivize industry to reformulate: e.g. 
extend SDIL to other drinks and foods high in sugar  
Restrict price promotions on unhealthier foods 
Increase affordability of fruit and vegetables for 
low -income families 
 
Marketing 
Restrict advertising and sponsorship to reduce 
exposure of children to unhealthy food 
Mandate point of choice information: e.g. calorie 
labelling in the out of home sector 
Availability 
Increase availability of lower salt products and 
reduce availability of higher salt products, through 
voluntary or mandatory programmes 
Enforce and extend food buying standards in public 
sector outlets including schools, hospitals, local and 
national government agencies 
Restrict placement of unhealthier foods in high-
sales areas including aisle ends and checkouts  
Mandate smaller portions of ready-to-eat foods 
Activity-Related 
Fiscal and economic policies 
Tax to shift affordability to public transport and 
away from car use; e.g. reinstate fuel duty escalator 
Road user pricing: e.g. parking and congestion zone 
charging 
Marketing 
Mass media campaigns e.g. This Girl Can 
Availability 
‘Whole system’ spatial planning to promote 
physical activity including integrated public 
transport, high walkability and cycleability given 
safe and attractive infrastructure 
Regular mass participation events: e.g. parkrun UK 
  5 
Panel Legend 
 
The list of interventions included is informed by the World Health Organization report on ‘best 
buys’29 to prevent non-communicable diseases,29 and the Bloomberg Philanthropies report on fiscal 
policies for health 14. 
 
To note 
1. There will be synergies between some of the recommended interventions such that their 
cumulative effect will be greater than their introduction as single components; e.g. the effect 
of fiscal and economic policies concerning travel will be greater if combined with 
appropriate spatial planning approaches and development of safe attractive infrastructure 
for walking and cycling.  
2. Implementing all of these interventions would be the starting point for making the step-
change needed to show improvements in population health and reduce the gap in health 
between the richest and the poorest in England. Further population level interventions, 
based on the principles outlined above, are likely to be necessary. 
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